Bank of New York Mellon Corp - BIND THERAPEUTICS INC ownership

BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 39 filers reported holding BIND THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BIND THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$37,000
-2.6%
16,650
+0.0%
0.00%
Q4 2015$38,000
-48.6%
16,6490.0%0.00%
Q3 2015$74,000
-20.4%
16,6490.0%0.00%
Q2 2015$93,000
+32.9%
16,649
+31.2%
0.00%
Q1 2015$70,000
-72.9%
12,687
-41.1%
0.00%
Q1 2014$258,00021,5250.00%
Other shareholders
BIND THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 2,018,253$9,001,0006.13%
FNY Managed Accounts LLC 30,000$133,800,0000.37%
Rhenman & Partners Asset Management AB 133,535$596,0000.10%
THOMPSON DAVIS & CO., INC. 4,500$20,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 26,000$116,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 83,593$373,0000.01%
VANGUARD GROUP INC 5,488,396$177,885,0000.01%
Alyeska Investment Group, L.P. 114,786$512,0000.01%
Renaissance Technologies 269,300$1,201,0000.00%
PRINCIPAL FINANCIAL GROUP INC 324,900$1,449,0000.00%
View complete list of BIND THERAPEUTICS INC shareholders